Methods and criteria used in evidence-based decisions in public health

Thyroid

Volumn 15, Issue 1, 2005, Pages 41-43

  Boyle, Coleen A ^a   Ladenson, Paul ^b   Haddow, James E ^c  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FOUNDATION FOR BLOOD RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; CONSENSUS; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; FEMALE; FETUS DEVELOPMENT; FETUS WASTAGE; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; HYPOTHYROIDISM; INCIDENCE; LEGAL ASPECT; MEDICAL DECISION MAKING; NEUROPSYCHOLOGY; PRACTICE GUIDELINE; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PUBLIC HEALTH; RISK BENEFIT ANALYSIS; SCREENING TEST; SOCIAL ASPECT; THYROID DISEASE; THYROID FUNCTION TEST; THYROTOXICOSIS; WORKSHOP;

EID: 13544259659     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2005.15.41     Document Type: Conference Paper

References (12)

1. Institute of Medicine 1990 Definition of key terms. In: Field MJ, Lohr KN, (eds) Publications of the Institute of Medicine. National Academy Press, Washington, D.C., pp. 33-51.
2. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC 1992 A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. JAMA 268:240-248.
3. Khan S, William P, Sutton R 1998 Meta-analyses and large randomized, controlled trials. N Engl J Med 338:59-62.
4. McAlister FA, Clark HD, van Walraven C, Straus SE, Lawson FM, Moher D, Mulrow CD 1999 The medical review article revisited: has the science improved? Ann Intern Med 131:947-951.
5. Shekelle PG, Woolf SH, Eccles M, Grimshaw J 1999 Clinical guidelines: developing guidelines. BMJ 318:593-596.
6. Belin RM, Ladenson PW, Robinson KA, Powe NR 2002 Development and use of evidence-based clinical practice guidelines for thyroid disease. Endocrinol Metab Clin North Am 31:795-817.
7. Danese MD, Powe NR, Sawin CT, Ladenson PW 1996 Screening for mild thyroid failure at the periodic health examination: A decision and cost-effectiveness analysis. JAMA 276:285-292.
8. Eccles M, Mason J, Freemantle N 2000 Developing valid cost effectiveness guidelines: A methodological report from the North of England evidence based guideline development project. Qual Health Care 9:127-132.
9. Russell LB, Siegel JE, Daniels N, Gold MR, Luce BR, Mandelblatt JS. 1996 Cost-effectiveness analysis as a guide to resource allocation in health: roles and limitations. In: Gold M, Seigel J, Russell L (eds) Cost-Effectiveness in Health and Medicine. Oxford University Press, New York, pp. 3-24.
10. Wald NJ 1994 Guidance on terminology. J Med Screen 1:76.
11. Wald N, Cuckle H 1989 Reporting the assessment of screening and diagnostic tests. Br J Obstet Gynaecol 96:389-396.
12. Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, O'Heir CE, Mitchell ML, Hermos RJ, Waisbren SE, Faix JD, Klein RZ 1999 Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341:549-555.